Ontology highlight
ABSTRACT:
SUBMITTER: Groselj B
PROVIDER: S-EPMC3590661 | biostudies-literature | 2013 Mar
REPOSITORIES: biostudies-literature
Groselj B B Sharma N L NL Hamdy F C FC Kerr M M Kiltie A E AE
British journal of cancer 20130129 4
Many cancers display increased expression of histone deacetylases (HDACs) and therefore transcriptionally inactive chromatin, resulting in the downregulation of genes including tumour suppressor and DNA repair genes. Histone deacetylase inhibitors (HDACi) are a heterogeneous group of epigenetic therapeutics, showing promising anticancer effects in both pre-clinical and clinical settings, in particular the effect of radiosensitisation when administered in combination with radiotherapy. Radiothera ...[more]